We hope you stay safe by following safety protocols issued by your local governmental body amid the escalation of Covid-19 to a pandemic. In the meantime, we would like to provide you with an update regarding business continuity here at NEXEL Co. Ltd.
NEXEL is making every effort to make sure our production and projects are not disrupted, all the while taking the necessary safety measures. Despite Covid-19 being mainly contained in the city of Daegu, our staff have implemented the following initiatives as precautionary measures:
-No visitor policy and disinfection upon entering NEXEL offices
-Work-from-home initiatives where possible
-No public transport during rush hour
-Flexible lunch hours to avoid packed restaurants
-No after-work gatherings
The Covid-19 pandemic and these initiatives do not disrupt NEXEL’s production or services currently. We will make it a priority to update you as soon as there is a change.
Our customer support and sales team is ready to help out as usual – reach out to them at firstname.lastname@example.org should any questions arise concerning changes to your requirements.
2020 is an exciting year for NEXEL Co. Ltd. as we started it by becoming the first South Korean company to participate in the CiPA myocyte study group organized by HESI in preparation for the ICH S7B revision. We aim to overcome this period of difficulty and show off to the world the quality of our products, which are proving to be up to global standards and more.
Thank you for your continued support and interest.
March 20, 2020
NEXEL Co. Ltd.